Search details
1.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Article
in English
| MEDLINE | ID: mdl-38594880
2.
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study.
Jpn J Clin Oncol
; 54(2): 175-181, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-37899139
3.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38517658
4.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38494578
5.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38353907
6.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38649648
7.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38526621
8.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38538963
9.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38578596
10.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38696053
11.
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.
Cancer Sci
; 114(11): 4343-4354, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37715310
12.
Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice.
Acta Med Okayama
; 77(1): 65-70, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36849147
13.
Identification of targetable kinases in idiopathic pulmonary fibrosis.
Respir Res
; 23(1): 20, 2022 Feb 07.
Article
in English
| MEDLINE | ID: mdl-35130915
14.
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Int J Clin Oncol
; 27(7): 1139-1144, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35534642
15.
COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma.
Acta Med Okayama
; 76(5): 593-596, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-36352807
16.
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Cancer Sci
; 112(5): 1853-1864, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33410241
17.
Secretory carcinoma of the skin with lymph node metastases and recurrence in both lungs: A case report.
J Cutan Pathol
; 48(8): 1069-1074, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33882152
18.
A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Jpn J Clin Oncol
; 51(6): 956-965, 2021 May 28.
Article
in English
| MEDLINE | ID: mdl-33829270
19.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Article
in English
| MEDLINE | ID: mdl-34115855
20.
Demand for weekend outpatient chemotherapy among patients with cancer in Japan.
Support Care Cancer
; 29(3): 1287-1291, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-32621265